Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Ann Leen, PhD, Ifigeneia Tzannou, MD, Munu Bilgi, Hao Liu, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD, Rammurti T Kamble, MD, Carlos A. Ramos, MD, Bambi Grilley, RPh, Adrian P. Gee, PhD, Catherine M. Bollard, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, George Carrum, MD

Blood (2015) 126 (23): 186.

https://doi.org/10.1182/blood.V126.23.186.186

Published: 2015

Journal Articles

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Ifigeneia Tzannou, MD, Bilal Omer, MD, Anastasia Papadopoulou, PhD, Ulrike Gerdemann, MD, Colton Smith, PhD, Adrian P. Gee, PhD, Bambi J Grilley, Malcolm K. Brenner, MB, PhD FRCP, FRCPath, Catherine M. Bollard, MD, Ann M. Leen, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2015) 126 (23): 1926.

https://doi.org/10.1182/blood.V126.23.1926.1926

Published: 2015

Journal Articles

Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant

Ulrike Gerdemann, MD, Usha L Katari, Jacqueline Keirnan, John A. Craddock, M.D., Janet Salinas, Hao Liu, PhD, Caridad Martinez, MD, Alana Kennedy-Nasser, MD, Kathryn Leung, MD, Stephen Gottschalk, MD, Adrian P. Gee, PhD, Robert A. Krance, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Ann M. Leen, PhD

Blood (2012) 120 (21): 223.

https://doi.org/10.1182/blood.V120.21.223.223

Published: 2012

Journal Articles

Improving T Cell Therapy for Relapsed EBV-Negative Hodgkin's Lymphoma by Targeting Upregulated MAGE-A4

Conrad Russell Y. Cruz, MD, Ulrike Gerdemann, MD, Ann M. Leen, PhD, Jessica A. Shafer, MD, Stephanie Ku, BS, Benjamin Tzou, BS, Terzah M. Horton, MD, PhD, Amanda Copeland, MSN, Anas Younes, MD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Catherine M. Bollard, MD

Blood (2011) 118 (21): 1658.

https://doi.org/10.1182/blood.V118.21.1658.1658

Published: 2011

Journal Articles

Genetic Modification of Multi Leukemia Antigen-Specific Cytotoxic T Lymphocytes (CTL) to Enhance In Vivo Safety and Persistency

Fabian Zohren, MD, Maria R Imperato, Anurathapan Usanarat, MD, David M Spencer, PhD, Helen E. Heslop, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Cliona M. Rooney, PhD, Ann M. Leen, PhD, Juan F Vera, MD, Ulrike Gerdemann, MD

Blood (2011) 118 (21): 644.

https://doi.org/10.1182/blood.V118.21.644.644

Published: 2011

Journal Articles

The Lymphoblastic Leukemia Gene 1 (Lyl1) Regulates Lymphoid Specification and Maintenance of Early T Lineage Progenitors

Fabian Zohren, MD, George Souroullas, PhD, Min Luo, Ph.D., Ulrike Gerdemann, MD, Nicola K Wilson, Berthold Göttgens, DPhil, Georgi L. Lukov, MD, PhD, Margaret Goodell, Ph.D.

Blood (2011) 118 (21): 548.

https://doi.org/10.1182/blood.V118.21.548.548

Published: 2011

Journal Articles

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Carlos A. Ramos, MD, Neeharika Narala, MSc, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Matthew L. Anderson, MD, PhD, Erich M. Sturgis, MD, MPH, Barbara Savoldo, MD, PhD, Helen E. Heslop, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 1913.

https://doi.org/10.1182/blood.V118.21.1913.1913

Published: 2011

Journal Articles

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Gerrit Weber, MD, Ulrike Gerdemann, MD, Nancy F. Hensel, BS, Ann M. Leen, PhD, Catherine M. Bollard, MD, A. John Barrett, MD

Blood (2011) 118 (21): 2985.

https://doi.org/10.1182/blood.V118.21.2985.2985

Published: 2011

Journal Articles

Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.

Ulrike Gerdemann, MD, Anne S. Christin, MD, Conrad Russell Cruz, MD, Carlos A. Ramos, MD, Donald R. Shaffer, Stephen Gottschalk, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, FRACP, FRCPA, Cliona M. Rooney, PhD, Ann M. Leen, PhD

Blood (2009) 114 (22): 4083.

https://doi.org/10.1182/blood.V114.22.4083.4083

Published: 2009

Journal Articles

Immune-Based Therapies Targeting Mage-A4 for Relapsed/Refractory Hodgkin's Lymphoma After Stem Cell Transplant.

Conrad Russell Y. Cruz, MD, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Anne S. Christin, MD, Tamara Tripic, PhD, Jessica Shafer, MD, Anas Younes, MD, Terzah M. Horton, MD, PhD, Elizabeth J. Shpall, MD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Catherine M. Bollard, MD, FRACP, FRCPA

Blood (2009) 114 (22): 4089.

https://doi.org/10.1182/blood.V114.22.4089.4089

Published: 2009

Journal Articles

Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients.

Ulrike Gerdemann, MD, Anne Christin, MD, Carlos A. Ramos, MD, Yuriko Fujita, MD, Juan F. Vera, MD, Dagmar Dilloo, MD, Malcolm K. Brenner, MD, PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Ann M. Leen, PhD

Blood (2008) 112 (11): 2207.

https://doi.org/10.1182/blood.V112.11.2207.2207

Published: 2008

NARROW

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant

Improving T Cell Therapy for Relapsed EBV-Negative Hodgkin's Lymphoma by Targeting Upregulated MAGE-A4

Genetic Modification of Multi Leukemia Antigen-Specific Cytotoxic T Lymphocytes (CTL) to Enhance In Vivo Safety and Persistency

The Lymphoblastic Leukemia Gene 1 (Lyl1) Regulates Lymphoid Specification and Maintenance of Early T Lineage Progenitors

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.

Immune-Based Therapies Targeting Mage-A4 for Relapsed/Refractory Hodgkin's Lymphoma After Stem Cell Transplant.

Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only